$GHST
GHST World Inc.

2022 Q3 Form 10-K Financial Statement

#000155335022000798 Filed on September 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $163.9K $150.7K
YoY Change 178.05% -0.44%
Operating Profit
YoY Change
Interest Expense $150.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.183K
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$163.9K -$151.9K
YoY Change 178.05% 0.34%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 124.4M shares 54.03M shares
Diluted Shares Outstanding 124.6M shares 54.03M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $882.00 $206.00
YoY Change -97.2%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $115.0K
YoY Change 0.0%
Total Long-Term Assets $39.18K $154.2K
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $882.00 $206.00
Total Long-Term Assets $39.18K $154.2K
Total Assets $40.06K $154.4K
YoY Change -4.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $92.64K $86.69K
YoY Change -65.12%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $92.64K $86.69K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$9.583M -$9.419M
YoY Change 1.64%
Common Stock $124.9K $124.4K
YoY Change 2274.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$52.58K $67.70K
YoY Change
Total Liabilities & Shareholders Equity $40.06K $154.4K
YoY Change -4.42%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$163.9K -$151.9K
YoY Change 178.05% 0.34%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$38.32K -$163.0K
YoY Change -32.88% 13.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $81.35K
YoY Change -45.21%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $38.99K $155.9K
YoY Change -27.57% -1.58%
NET CHANGE
Cash From Operating Activities -$38.32K -$163.0K
Cash From Investing Activities
Cash From Financing Activities $38.99K $155.9K
Net Change In Cash $676.00 -$7.144K
YoY Change -201.22%
FREE CASH FLOW
Cash From Operating Activities -$38.32K -$163.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity File Number
EntityFileNumber
000-31705
CY2022 dei Entity Registrant Name
EntityRegistrantName
GHST World Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2007477
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
667 Madison Avenue
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10065
CY2022 dei City Area Code
CityAreaCode
212
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001121795
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
usd
CY2021 us-gaap Interest Expense
InterestExpense
usd
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Local Phone Number
LocalPhoneNumber
634-6860
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
911327 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
124430534 shares
CY2022 dei Auditor Name
AuditorName
Ciro E. Adams, CPA, LLC
CY2022 dei Auditor Location
AuditorLocation
Wilmington, DE
CY2022 dei Auditor Firm
AuditorFirmId
5938
CY2022Q2 us-gaap Cash
Cash
206 usd
CY2021Q2 us-gaap Cash
Cash
7350 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
206 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
7350 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
115000 usd
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
115000 usd
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
39181 usd
CY2021Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
39181 usd
CY2022Q2 us-gaap Assets
Assets
154387 usd
CY2021Q2 us-gaap Assets
Assets
161531 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1685 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14528 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
75446 usd
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
16241 usd
CY2022Q2 GHST Common Stock Payable
CommonStockPayable
9559 usd
CY2021Q2 GHST Common Stock Payable
CommonStockPayable
217784 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
86690 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
248553 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124430534 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5239832 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
124431 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
5240 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9362205 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9174792 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9418947 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9267062 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
67697 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-87022 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154387 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
161531 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
150702 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
151366 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
150702 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
151366 usd
CY2022 us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
667 usd
CY2022 us-gaap Interest Expense
InterestExpense
150 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1700 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1183 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-151885 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-151366 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54032711 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4760534 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54032711 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4760534 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-109065 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
148478 usd
CY2021 GHST Issuance Of Shares In Exchange Of Debt
IssuanceOfSharesInExchangeOfDebt
24931 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-151366 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-87022 usd
CY2022 GHST Issuance Of Shares In Exchange Of Debt
IssuanceOfSharesInExchangeOfDebt
225259 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
81345 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-151885 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
67697 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-151885 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-151366 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1700 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12843 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7436 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-163028 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-143930 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7395 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7395 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
59205 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7905 usd
CY2022 us-gaap Proceeds From Repayment Of Loans To Purchase Common Stock
ProceedsFromRepaymentOfLoansToPurchaseCommonStock
15334 usd
CY2021 us-gaap Proceeds From Repayment Of Loans To Purchase Common Stock
ProceedsFromRepaymentOfLoansToPurchaseCommonStock
2000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
81345 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
148478 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155884 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
158383 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7144 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7058 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7350 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
292 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7350 usd
CY2022 GHST Issuance Of Common Stock In Exchange For Debt
IssuanceOfCommonStockInExchangeForDebt
225259 usd
CY2021 GHST Issuance Of Common Stock In Exchange For Debt
IssuanceOfCommonStockInExchangeForDebt
24931 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-151885 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-151366 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9418947 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
67697 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-163028 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-143930 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z3HpBf7G8lca" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_864_zWHfRkVzZct9">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_ziCkLWZVNIOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_860_zg2FmSDz8Fq5">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such estimates and assumptions impact, among others, the following: the fair value of share-based payments and deferred taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.4pt 0"><b> </b></p>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
16241 usd
CY2022Q2 GHST Common Stock Payable Related Parties
CommonStockPayableRelatedParties
9558 usd
CY2022 us-gaap Fair Value Asset Liability Recurring Basis Still Held Unrealized Gain Loss
FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss
0 usd
CY2021 us-gaap Fair Value Asset Liability Recurring Basis Still Held Unrealized Gain Loss
FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss
0 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7395 usd
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
39181 usd
CY2021Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
39181 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
152000 usd
CY2021Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
151000 usd
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
39181 usd
CY2021Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
39181 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-100 reverse stock split
CY2022Q2 GHST Common Stock Received
CommonStockReceived
9559 usd
CY2021Q2 GHST Common Stock Received
CommonStockReceived
217784 usd
CY2018Q2 GHST Common Stock Payable Shares
CommonStockPayableShares
2000000 shares
CY2018Q2 GHST Common Stock Payable Per Share Value
CommonStockPayablePerShareValue
0.001
CY2018Q2 GHST Common Stock Payable Value
CommonStockPayableValue
2000 usd
CY2022Q2 GHST Common Stock Payable Per Share Value
CommonStockPayablePerShareValue
0.00185
CY2022Q2 GHST Common Stock Payable Value
CommonStockPayableValue
3700 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1700 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
75446 usd
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
310000000 shares
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
300000000 shares
CY2021Q3 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
10000000 shares
CY2022 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
100-1 reverse stock split
CY2022 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
118663761 shares
CY2022Q2 us-gaap Share Price
SharePrice
0.0019
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
225259 usd
CY2022 GHST Sale Of Stock Number Of Share Issued In Transaction
SaleOfStockNumberOfShareIssuedInTransaction
526941 shares
CY2022 GHST Shares To Exchange Value
SharesToExchangeValue
81345 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9418947 usd
CY2022 GHST Operating Loss Description
OperatingLossDescription
the Company has operating loss carryforwards of approximately $2.8 million from tax years beginning before January 1, 2021, that begin to expire in 2027. These operating losses are subject to the limitations which were enacted in the Tax Cuts and Jobs Act (“TCJA”).
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2800000 usd
CY2022Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
700000 usd

Files In Submission

Name View Source Status
0001553350-22-000798-index-headers.html Edgar Link pending
0001553350-22-000798-index.html Edgar Link pending
0001553350-22-000798.txt Edgar Link pending
0001553350-22-000798-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ghst-20220630.xsd Edgar Link pending
ghst_10k.htm Edgar Link pending
ghst_ex31z1.htm Edgar Link pending
ghst_ex31z2a.htm Edgar Link pending
ghst_ex31z2b.htm Edgar Link pending
ghst_ex32z1.htm Edgar Link pending
image_004.jpg Edgar Link pending
image_005.jpg Edgar Link pending
image_006.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ghst-20220630_cal.xml Edgar Link unprocessable
ghst-20220630_pre.xml Edgar Link unprocessable
ghst-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ghst_10k_htm.xml Edgar Link completed
ghst-20220630_lab.xml Edgar Link unprocessable